September 11, 2024by Diabetologia Credit: Unsplash/CC0 Public DomainAs more people with type 2 diabetes (T2D) are taking medications to help manage blood sugar levels and weight loss, concerns about whether these drugs are safe have emerged. Now real-world evidence from the FDA Adverse Event Reporting System (FAERS) database reveals a reassuring safety profile for tirzepatide...
Tag: <span>T2D</span>
New Marker of Cardiovascular Risk Discovered in T2D
Anne-Gaëlle Moulun A significant quantity of dysfunctional monocytes appears to indicate poor cardiovascular prognosis in patients with type 2 diabetes, according to a new publication. Nicolas Venteclef, PhD, director of an Inserm institute for diabetes research at Necker Enfants Malades Hospital in Paris, France, led the research. Quantifying InflammationPatients with type 2 diabetes have about...
AAO: Diabetic retinopathy usually no worse with semaglutide in T2D
by Elana Gotkine For patients with type 2 diabetes mellitus, most eyes have no worsening of diabetic retinopathy (DR) after initiation of semaglutide, according to a study presented at the annual meeting of the American Academy of Ophthalmology, held from Nov. 3 to 6 in San Francisco. Zeeshan Haq, M.D., from Retina Consultants of Minnesota...
Another Study Ties Statins to T2D: Should Practice Change?
Marilynn Larkin October 30, 2023 Studies have shown links between statin use and type 2 diabetes (T2D) for more than a decade. A US Food and Drug Administration label change for the drugs warned in 2012 about reports of increased risks of high blood glucose and glycosylated hemoglobin (A1c) levels. However, in the same warning, the FDA...
First-Line Therapy in T2D: Has Metformin Been ‘Dethroned’?
Joshua J. Neumiller, PharmD, CDCES; Radica Z. Alicic, MD, MSc DISCLOSURES August 15, 2023Initially approved by the US Food and Drug Administration (FDA) in 1994, metformin has been the preferred first-line glucose-lowering agent for patients with type 2 diabetes (T2D) owing to its effectiveness, low hypoglycemia risk, weight neutrality, long clinical track record of safety,...
Low energy diets with formula meal replacements effective for weight management and remission in adults with T2D
by Diabetologia Credit: CC0 Public Domain A new study published in Diabetologia (the journal of the European Association for the Study of Diabetes [EASD]) finds that low energy diets with formula meal replacements are the most effective methods of weight management and remission in adults with type 2 diabetes (T2D), while the macronutrient content is not important to...